Palbociclib overcomes afatinib resistance in non-small cell lung cancer.
Biomed Pharmacother
; 109: 1750-1757, 2019 Jan.
Article
in En
| MEDLINE
| ID: mdl-30551429
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyridines
/
Carcinoma, Non-Small-Cell Lung
/
Drug Resistance, Neoplasm
/
Afatinib
/
Lung Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Biomed Pharmacother
Year:
2019
Document type:
Article
Country of publication:
France